Dr. Samuel Nathan Steerman, MD

Dr. Steerman practices at Sentara Virginia Beach General Hospital in Virginia Beach, Virginia, part of Sentara Health.

Dr. Steerman's NPI, 1639349335, was assigned on March 10, 2008. Dr. Steerman graduated from Jefferson Medical College of Thomas Jefferson University in 2006. Dr. Steerman holds Virginia license 0116023706.

Dr. Steerman's primary practice is Sentara Virginia Beach General Hospital, at 1060 First Colonial Road, Virginia Beach, VA 23454 in Virginia Beach City. The practice phone is (757) 395-8000.

Dr. Steerman's primary practice is Sentara Virginia Beach General Hospital in Virginia Beach, Virginia, part of Sentara Health. Dr. Steerman is also affiliated with Sentara Princess Anne Hospital. The medical group on file is Sentara Medical Group. Dmand AI also links Dr. Steerman to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Steerman practices, 8 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Steerman's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Steerman's licenses on file in 2 states: Virginia and Pennsylvania.

CMS data shows 3,680 Medicare services from Dr. Steerman across 38 procedure codes in 2024, for 2,636 Medicare patients. Medicare paid $276,626 for them.

CMS counts 2,636 Medicare patients who saw Dr. Steerman in 2024. The largest group is 75 to 84, with 1,066 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Steerman's median patient age at 65, with 52% women.

In 2024, Dr. Steerman wrote 225 Medicare Part D claims for 96 patients. 84% of them were for generic drugs. CMS names the drug for 197 of them, across 6 drugs with 11 or more claims each, at $32,233 in total drug cost. In 2023, CMS named 113 claims across 5 drugs.

Dr. Steerman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of leg revascularization (restoring blood flow) by Dr. Steerman, more than 86% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Steerman, published from 2012 to 2021. 2021 was the busiest year, with 2. The most frequent topics are Arteriovenous Shunt, Surgical, Catheterization, Peripheral and Chi-Square Distribution. Dr. Steerman has published most often in Ann Vasc Surg. Dr. Steerman's most frequent co-authors are Jean Michel Panneton, MD, Aleem Mirza, MD and Sadaf Sadie Ahanchi, MD.

Dmand AI links Dr. Steerman to 1 clinical trial. Conditions studied include Chronic Limb-Threatening Ischemia and Peripheral Arterial Disease.

CMS Open Payments shows 902 general payments to Dr. Steerman from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 39% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $192,979.

Dr. Steerman graduated from Jefferson Medical College of Thomas Jefferson University in 2006.